Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Scheiber

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Biomolecular Screening|June 18, 2009
Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversitySai Chetan K Sukuru, Jeremy L Jenkins, Rohan E J Beckwith, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 4, 2024
Sex-specific response of the human plasma lipidome to short-term cold exposureMarcus Höring, Sarah Brunner, Josef Scheiber, et al.
Bioorganic & Medicinal Chemistry|February 13, 2010
Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterasesVildan Alptüzün, Michaela Prinz, Verena Hörr, et al.
Chemmedchem|August 26, 2006
Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studiesRadim Vicik, Matthias Busemann, Christoph Gelhaus, et al.
Therapeutic Advances in Medical Oncology|October 3, 2022
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinomaLouisa Hempel, Constantin Lapa, Alexander Dierks, et al.
Journal of Medicinal Chemistry|March 25, 2008
"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hitsThomas J Crisman, Andreas Bender, Mariusz Milik, et al.
Journal of Proteome Research|March 11, 2009
Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography dataAndreas Bender, Dmitri Mikhailov, Meir Glick, et al.
Journal of Chemical Information and Modeling|July 5, 2007
Understanding false positives in reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS dataThomas J Crisman, Christian N Parker, Jeremy L Jenkins, et al.
Journal of Medicinal Chemistry|April 22, 2009
Mapping adverse drug reactions in chemical spaceJosef Scheiber, Jeremy L Jenkins, Sai Chetan K Sukuru, et al.
Current Opinion in Drug Discovery & Development|April 23, 2008
Which aspects of HTS are empirically correlated with downstream success?Andreas Bender, Dejan Bojanic, John W Davies, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Biomolecular Screening|June 18, 2009
Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversitySai Chetan K Sukuru, Jeremy L Jenkins, Rohan E J Beckwith, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 4, 2024
Sex-specific response of the human plasma lipidome to short-term cold exposureMarcus Höring, Sarah Brunner, Josef Scheiber, et al.
Bioorganic & Medicinal Chemistry|February 13, 2010
Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterasesVildan Alptüzün, Michaela Prinz, Verena Hörr, et al.
Chemmedchem|August 26, 2006
Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studiesRadim Vicik, Matthias Busemann, Christoph Gelhaus, et al.
Therapeutic Advances in Medical Oncology|October 3, 2022
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinomaLouisa Hempel, Constantin Lapa, Alexander Dierks, et al.
Journal of Medicinal Chemistry|March 25, 2008
"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hitsThomas J Crisman, Andreas Bender, Mariusz Milik, et al.
Journal of Proteome Research|March 11, 2009
Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography dataAndreas Bender, Dmitri Mikhailov, Meir Glick, et al.
Journal of Chemical Information and Modeling|July 5, 2007
Understanding false positives in reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS dataThomas J Crisman, Christian N Parker, Jeremy L Jenkins, et al.
Journal of Medicinal Chemistry|April 22, 2009
Mapping adverse drug reactions in chemical spaceJosef Scheiber, Jeremy L Jenkins, Sai Chetan K Sukuru, et al.
Current Opinion in Drug Discovery & Development|April 23, 2008
Which aspects of HTS are empirically correlated with downstream success?Andreas Bender, Dejan Bojanic, John W Davies, et al.
Pageof 3